Premier Alternatives

Luminopia

Cambridge, MA · Founded 2016 · Privately Held (backing)

Developer of a binocular therapeutic device designed to pioneer a new class of treatments for significant neuro-visual disorders. Luminopia is based in Cambridge, MA and was founded in 2016. It was valued at $44 million at its later-stage round in Jun 2023, the last priced event on record. It has raised $37.8 million across 5 recorded rounds; the latest was a $15.8 million early-stage round in Jun 2023.

PMV mark · valuation
$44.0M
Oct 2026
Priced at
its later-stage round
Jun 2023
Total raised
$37.8M
Last round
Early Stage VC
Jun 2023

Luminopia key facts

as of Oct 2026
  • Developer of a binocular therapeutic device designed to pioneer a new class of treatments for significant neuro-visual disorders.
  • Luminopia is valued at approximately $44.0M as of Oct 2026, set at its later-stage round, Jun 2023; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $37.8M across 5 recorded rounds; the latest was Early Stage VC ($15.8M) in Jun 2023.
  • Notable investors include MassChallenge, Collaborative Fund, Harvard Innovation Launch Lab, Sony Innovation Fund, Bantam Group — 18 tracked in total.
  • Luminopia has filed 5 Form Ds with the SEC since 2017, most recently Jun 2023 ($15.8M sold to 10 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$44.0M

Valued at $44.0M at its later-stage round, Jun 2023. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Luminopia with a free account
  • ·The complete investor list: 18 names
  • ·Watch Luminopia: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Luminopia funding rounds

5 rounds
Jun 2023Early Stage VC$15.8MSEC filing▮
Oct 2022Seed Round$4.1MSEC filing▮
Nov 2019Early Stage VC$11.1MSEC filing▮
Sep 2017Seed Round$1.3MSEC filing▮
Jun 2017Seed Round$3.6MSEC filing▮
Full funding history →

Luminopia valuation

Luminopia was valued at $44 million at its later-stage round in Jun 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Luminopia raised?

Luminopia has raised $37.8 million across 5 recorded rounds since 2017. The largest was a $4.1 million seed round in Oct 2022; the most recent was a $15.8 million early-stage round in Jun 2023.

Luminopia has filed 5 Form Ds with the SEC since 2017, most recently in Jun 2023 ($15.8 million sold to 10 investors).

Luminopia investors

18 investors are on record for Luminopia, including MassChallenge, Collaborative Fund, Harvard Innovation Launch Lab and Sony Innovation Fund. The early-stage round in Jun 2023 drew 10 investors.

About Luminopia

Developer of a binocular therapeutic device designed to pioneer a new class of treatments for significant neuro-visual disorders. The company offers treatment for amblyopia, or lazy eye, using binocular vision and is developing a product to treat amblyopia which is the leading cause of vision loss among children, enabling healthcare professionals to treat significant neuro-visual disorders.

Sector
Healthcare
HQ
Cambridge, MA, United States
Founded
2016
Employees
23
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.